SlideShare a Scribd company logo
1 of 39
Meet Molecular Architect Dr Mark Mackey Chief Scientifc Officer
Outline Fields, Field points and the good things you can do with them The alignment problem 3D-QSAR using Fields Examples SARS PLpro – small data set, known xtal structure NK3 – large data set, unknown xtal structure
Field Points Condensed representation of electrostatic, hydrophobic and shape properties (“protein’s view”)  Molecular Field Extrema (“Field Points”) = Positive  = Negative = Shape = Hydrophobic 3D Molecular Electrostatic Potential (MEP) Field Points 2D
+ve ionic H-bond acceptor Aromatic      p cloud ‘H acceptor’ -ve ionic H-bond donor Hydrophobes Aromatic   in-plane ‘H donor’ “Stickiest” surfaces (high vdW) Field points give you new insights into your molecule Explanatory Power of Fields = Positive  = Negative = Shape = Hydrophobic Field point sizes show importance
Field Points have lots of applications Virtual screening Alignment Pharmacophore elucidation Bioisosteres etc
Field Points have lots of applications Virtual screening Alignment Pharmacophore elucidation Bioisosteres etc What about 3D QSAR?
The Alignment Problem Historically very difficult Early approaches template-based Issues with side chain orientations Some success with docked data sets Easy to fool yourself Correlation/causation
Alignment issues Ligand-centric view vs protein-centric Cramer, JCAMD, 2010, DOI 10.1007/s10822-010-9403-z
Which is better? “The superior statistical qualities of 3D-QSAR models based on poses that superimpose presumably critical ligand features, rather than docked conformations.” Clark R., JCAMD 2007, p587 Doweyko, J. Comp-Aided Mol. Des., 2004, p 587 Free alignment adds signal, but also noise.  Worse statistics, better predictability?
N-methyl acetamide Imidazole Field Alignment
N-methyl acetamide Imidazole Field Scoring To score a particular alignment, we use the field points of molecule 1 to sample the actual field of molecule 2 Cheeseright et al, J. Chem Inf. Mod., 2006, 665
Field Scoring N-methyl acetamide Imidazole To score a particular alignment, we use the field points of molecule 1 to sample the actual field of molecule 2 and vice-versa Cheeseright et al, J. Chem Inf. Mod., 2006, 665
Field Sampling Field-point based QSAR descriptors
Field Sampling Field-point based QSAR descriptors
Advantages Many fewer sample points than grid-based methods E.g. Vegfr2 data set  Du et al., J Mol Graph Model. 27 (2009) 642-652
Advantages Many fewer sample points than grid-based methods Sample points physically rather than statistically chosen Gauge invariant Consistent framework for alignment and QSAR
Initial validation Tested against literature CoMFA datasets 15 datasets with alignments available CoMFA average cross-validated RMSE is 0.72 Field QSAR using CoMFA alignments is 0.74 Simple model (volume indicator variable) is 0.83 Data sets re-aligned using field alignment RMSE 1.00
Interpretability Electrostatic Steric Variance
SARS PLpro
The target PLpro (Papain-like protease) is a DUB target which is critical for the replication of the coronavirus responsible for SARS Crystal structures available with bound ligands from 2 series of compounds: structurally related (PDB entries 3E9S and 3MJ5) Small number of analogues – challenge to see if we can use 3D-QSAR for small data sets
Alignment
Sampling points
Model PLS Components = 5  RMSE = 0.09  RMSEP = 0.38
Summary Able to build a predictive 3D-QSAR model based on small number of analogues Guided (by volume of Xtal structure) alignment worked best. Free alignment was OK, but noisier.
NK3 antagonists
NK3 example GPCR target (Tachykinin receptor 3) – selectively binds Neurokinin B – target for treatment of neurological disorders such as schizophrenia Three series of inhibitors from Euroscreen Scaffold-1 – 81 compounds with pIC50 (radioligand binding) in range 4.6-8.7 Scaffold-2 – 80 compounds with pIC50 in range 4.8-7.7 Errors in radioligand binding data c. ± 0.4
NK3 binding mode For a 3D method you need a 3D alignment FieldAlign can align to a reference FieldTemplater generates the reference FieldTemplater
NK3 binding mode prediction FieldTemplater Selection of 3 highly active scaffold-1 compounds plus 2 structurally dissimilar literature NK3 actives (Talnetant and SB-218795). Generated Templates filtered and candidate selected Conformation of most active scaff-1 structure then used as alignment target for other structures
3D-QSAR details Alignment Free alignment to template conformation Field selection Generated Field points for both steric and electrostatic fields, with both sets at independent locations. 80/20 training/test split  Most active and least active  training set 2nd most active, 2nd least active  test set Random distribution of remaining compounds
Initial models problematic When all else fails, talk to the chemists “Are you using the right tautomer?”
NK3 Series 1 RMSE 0.19, RMSEpred 0.64
NK3 Series 1 Sterics Electrostatics
Extend to scaff-2? Complete lack of predictivity Visual analysis suggests a shift in binding mode for scaff-2 Cross-series QSAR difficult Requires consistent binding modes!
NK1 Scaffold 2 RMSEpred 0.60
Summary Able to generate models based on alignment to predicted active conformation by templating Independent models within each of two series show reasonable predictivity and can be used to guide further work Cross-series analysis suggests different binding modes for the two series
Molecular Architect
Molecular Architect Initially FieldAlign + QSAR Align your molecules Build models Test models Fit new compounds to models Interactive feedback Add additional alignment options
Molecular Architect One tool for molecule designers Align QSAR Pharmacophore elucidation Bioisosteres What do I make next? Beta Q4 2011
Acknowledgements Cresset Andy Vinter Tim Cheeseright James Melville Chris Earnshaw Euroscreen Hamid Hoveyda JulienParcq

More Related Content

Viewers also liked

New features in cresst products
New features in cresst productsNew features in cresst products
New features in cresst productsCresset
 
Rob Scoffin, Cresset, 'The Cresset Future'
Rob Scoffin, Cresset, 'The Cresset Future'Rob Scoffin, Cresset, 'The Cresset Future'
Rob Scoffin, Cresset, 'The Cresset Future'Cresset
 
Smart drug re profiling using computational chemistry tools novel biology and...
Smart drug re profiling using computational chemistry tools novel biology and...Smart drug re profiling using computational chemistry tools novel biology and...
Smart drug re profiling using computational chemistry tools novel biology and...Cresset
 
Comparing the electrostatic properties of protein active sites and other cres...
Comparing the electrostatic properties of protein active sites and other cres...Comparing the electrostatic properties of protein active sites and other cres...
Comparing the electrostatic properties of protein active sites and other cres...Cresset
 
Matched molecular pair and activity cliffs published
Matched molecular pair and activity cliffs publishedMatched molecular pair and activity cliffs published
Matched molecular pair and activity cliffs publishedCresset
 
ICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRP
ICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRPICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRP
ICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRPDr. Haxel Consult
 
DRUG DESIGN AND DISCOVERY
DRUG DESIGN AND DISCOVERY DRUG DESIGN AND DISCOVERY
DRUG DESIGN AND DISCOVERY Rahul B S
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Designbaoilleach
 

Viewers also liked (9)

New features in cresst products
New features in cresst productsNew features in cresst products
New features in cresst products
 
Rob Scoffin, Cresset, 'The Cresset Future'
Rob Scoffin, Cresset, 'The Cresset Future'Rob Scoffin, Cresset, 'The Cresset Future'
Rob Scoffin, Cresset, 'The Cresset Future'
 
Smart drug re profiling using computational chemistry tools novel biology and...
Smart drug re profiling using computational chemistry tools novel biology and...Smart drug re profiling using computational chemistry tools novel biology and...
Smart drug re profiling using computational chemistry tools novel biology and...
 
Comparing the electrostatic properties of protein active sites and other cres...
Comparing the electrostatic properties of protein active sites and other cres...Comparing the electrostatic properties of protein active sites and other cres...
Comparing the electrostatic properties of protein active sites and other cres...
 
Matched molecular pair and activity cliffs published
Matched molecular pair and activity cliffs publishedMatched molecular pair and activity cliffs published
Matched molecular pair and activity cliffs published
 
ICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRP
ICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRPICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRP
ICIC 2014 Knowledge-Based De Novo Molecular Design Using ICSYNTH FRP
 
DRUG DESIGN AND DISCOVERY
DRUG DESIGN AND DISCOVERY DRUG DESIGN AND DISCOVERY
DRUG DESIGN AND DISCOVERY
 
Computational Drug Design
Computational Drug DesignComputational Drug Design
Computational Drug Design
 
Computer Aided Drug Design ppt
Computer Aided Drug Design pptComputer Aided Drug Design ppt
Computer Aided Drug Design ppt
 

Similar to Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

Lecture: Interatomic Potentials Enabled by Machine Learning
Lecture: Interatomic Potentials Enabled by Machine LearningLecture: Interatomic Potentials Enabled by Machine Learning
Lecture: Interatomic Potentials Enabled by Machine LearningDanielSchwalbeKoda
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipRaniBhagat1
 
Electron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein ModelingElectron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein ModelingN. Sukumar
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)Pinky Vincent
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 
Gordon2003
Gordon2003Gordon2003
Gordon2003toluene
 
Multisite UTE 31P Rosette MRSI(PETALUTE)
Multisite UTE 31P Rosette MRSI(PETALUTE)Multisite UTE 31P Rosette MRSI(PETALUTE)
Multisite UTE 31P Rosette MRSI(PETALUTE)Uzay Emir
 
36x42_phdposters_template-3
36x42_phdposters_template-336x42_phdposters_template-3
36x42_phdposters_template-3Océane Boulais
 
2019-06-07 Characterization and research of semiconductors with an FTIR spect...
2019-06-07 Characterization and research of semiconductors with an FTIR spect...2019-06-07 Characterization and research of semiconductors with an FTIR spect...
2019-06-07 Characterization and research of semiconductors with an FTIR spect...LeonidBovkun
 
SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...
SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...
SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...Jon Ernstberger
 
In it seminar_r_d_mos_cut
In it seminar_r_d_mos_cutIn it seminar_r_d_mos_cut
In it seminar_r_d_mos_cutjpdacosta
 
Comparing Cahn-Ingold-Prelog Rule Implementations
Comparing Cahn-Ingold-Prelog Rule ImplementationsComparing Cahn-Ingold-Prelog Rule Implementations
Comparing Cahn-Ingold-Prelog Rule ImplementationsNextMove Software
 
QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...
QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...
QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...Kamel Mansouri
 
Molecular Simulation to build models for enzyme induced fit
Molecular Simulation to build models for enzyme induced fit Molecular Simulation to build models for enzyme induced fit
Molecular Simulation to build models for enzyme induced fit MinSung Kim
 
Presentation_Guccione.pptx
Presentation_Guccione.pptxPresentation_Guccione.pptx
Presentation_Guccione.pptxgrssieee
 
Phil. Trans. R. Soc. B-2013-Michalet-
Phil. Trans. R. Soc. B-2013-Michalet-Phil. Trans. R. Soc. B-2013-Michalet-
Phil. Trans. R. Soc. B-2013-Michalet-Fabrizio Guerrieri
 
Small Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity DataSmall Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity DataRajarshi Guha
 

Similar to Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions' (20)

Lecture: Interatomic Potentials Enabled by Machine Learning
Lecture: Interatomic Potentials Enabled by Machine LearningLecture: Interatomic Potentials Enabled by Machine Learning
Lecture: Interatomic Potentials Enabled by Machine Learning
 
Protein Threading
Protein ThreadingProtein Threading
Protein Threading
 
3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis3 D QSAR Approaches and Contour Map Analysis
3 D QSAR Approaches and Contour Map Analysis
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
Qsar
QsarQsar
Qsar
 
Electron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein ModelingElectron Density Derived Descriptors in Drug Discovery and Protein Modeling
Electron Density Derived Descriptors in Drug Discovery and Protein Modeling
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
Gordon2003
Gordon2003Gordon2003
Gordon2003
 
Multisite UTE 31P Rosette MRSI(PETALUTE)
Multisite UTE 31P Rosette MRSI(PETALUTE)Multisite UTE 31P Rosette MRSI(PETALUTE)
Multisite UTE 31P Rosette MRSI(PETALUTE)
 
36x42_phdposters_template-3
36x42_phdposters_template-336x42_phdposters_template-3
36x42_phdposters_template-3
 
2019-06-07 Characterization and research of semiconductors with an FTIR spect...
2019-06-07 Characterization and research of semiconductors with an FTIR spect...2019-06-07 Characterization and research of semiconductors with an FTIR spect...
2019-06-07 Characterization and research of semiconductors with an FTIR spect...
 
SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...
SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...
SPIE 2009 - "Efficient Parameter Estimation Techniques for Hysteresis Models"...
 
In it seminar_r_d_mos_cut
In it seminar_r_d_mos_cutIn it seminar_r_d_mos_cut
In it seminar_r_d_mos_cut
 
Comparing Cahn-Ingold-Prelog Rule Implementations
Comparing Cahn-Ingold-Prelog Rule ImplementationsComparing Cahn-Ingold-Prelog Rule Implementations
Comparing Cahn-Ingold-Prelog Rule Implementations
 
QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...
QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...
QSAR STUDY ON READY BIODEGRADABILITY OF CHEMICALS. Presented at the 3rd Chemo...
 
Molecular Simulation to build models for enzyme induced fit
Molecular Simulation to build models for enzyme induced fit Molecular Simulation to build models for enzyme induced fit
Molecular Simulation to build models for enzyme induced fit
 
Presentation_Guccione.pptx
Presentation_Guccione.pptxPresentation_Guccione.pptx
Presentation_Guccione.pptx
 
Phil. Trans. R. Soc. B-2013-Michalet-
Phil. Trans. R. Soc. B-2013-Michalet-Phil. Trans. R. Soc. B-2013-Michalet-
Phil. Trans. R. Soc. B-2013-Michalet-
 
Small Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity DataSmall Molecules and siRNA: Methods to Explore Bioactivity Data
Small Molecules and siRNA: Methods to Explore Bioactivity Data
 

More from Cresset

Selectivity mining – multiple activities in Activity Miner
Selectivity mining – multiple activities in Activity MinerSelectivity mining – multiple activities in Activity Miner
Selectivity mining – multiple activities in Activity MinerCresset
 
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...Cresset
 
Can field based chemistry help us to predict protein-DNA binding sites?
Can field based chemistry help us to predict protein-DNA binding sites?Can field based chemistry help us to predict protein-DNA binding sites?
Can field based chemistry help us to predict protein-DNA binding sites?Cresset
 
Organic converstions: an aid in perspective
Organic converstions: an aid in perspectiveOrganic converstions: an aid in perspective
Organic converstions: an aid in perspectiveCresset
 
Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...Cresset
 
Knowledge-based chemical fragment analysis in protein binding sites
Knowledge-based chemical fragment analysis in protein binding sitesKnowledge-based chemical fragment analysis in protein binding sites
Knowledge-based chemical fragment analysis in protein binding sitesCresset
 
Using waterswap to predict and understand binding affinities
Using waterswap to predict and understand binding affinitiesUsing waterswap to predict and understand binding affinities
Using waterswap to predict and understand binding affinitiesCresset
 
Smart drug re-profiling using computational chemistry tools novel biology and...
Smart drug re-profiling using computational chemistry tools novel biology and...Smart drug re-profiling using computational chemistry tools novel biology and...
Smart drug re-profiling using computational chemistry tools novel biology and...Cresset
 
Torch for medicinal chemists
Torch for medicinal chemistsTorch for medicinal chemists
Torch for medicinal chemistsCresset
 
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...Cresset
 
Intelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond spIntelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond spCresset
 
Intelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond spIntelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond spCresset
 
Finding and using activity cliffs in 3D: Gaining more SAR information during ...
Finding and using activity cliffs in 3D: Gaining more SAR information during ...Finding and using activity cliffs in 3D: Gaining more SAR information during ...
Finding and using activity cliffs in 3D: Gaining more SAR information during ...Cresset
 
Tim Cheeseright, Assessing the Similarities of Compound collections using mol...
Tim Cheeseright, Assessing the Similarities of Compound collections using mol...Tim Cheeseright, Assessing the Similarities of Compound collections using mol...
Tim Cheeseright, Assessing the Similarities of Compound collections using mol...Cresset
 
David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'
David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'
David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'Cresset
 
Cresset: 25 year of Fields
Cresset: 25 year of FieldsCresset: 25 year of Fields
Cresset: 25 year of FieldsCresset
 
Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'
Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'
Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'Cresset
 
Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...
Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...
Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...Cresset
 
Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?
Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?
Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?Cresset
 

More from Cresset (19)

Selectivity mining – multiple activities in Activity Miner
Selectivity mining – multiple activities in Activity MinerSelectivity mining – multiple activities in Activity Miner
Selectivity mining – multiple activities in Activity Miner
 
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
 
Can field based chemistry help us to predict protein-DNA binding sites?
Can field based chemistry help us to predict protein-DNA binding sites?Can field based chemistry help us to predict protein-DNA binding sites?
Can field based chemistry help us to predict protein-DNA binding sites?
 
Organic converstions: an aid in perspective
Organic converstions: an aid in perspectiveOrganic converstions: an aid in perspective
Organic converstions: an aid in perspective
 
Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...Identification of novel potential anti cancer agents using network pharmacolo...
Identification of novel potential anti cancer agents using network pharmacolo...
 
Knowledge-based chemical fragment analysis in protein binding sites
Knowledge-based chemical fragment analysis in protein binding sitesKnowledge-based chemical fragment analysis in protein binding sites
Knowledge-based chemical fragment analysis in protein binding sites
 
Using waterswap to predict and understand binding affinities
Using waterswap to predict and understand binding affinitiesUsing waterswap to predict and understand binding affinities
Using waterswap to predict and understand binding affinities
 
Smart drug re-profiling using computational chemistry tools novel biology and...
Smart drug re-profiling using computational chemistry tools novel biology and...Smart drug re-profiling using computational chemistry tools novel biology and...
Smart drug re-profiling using computational chemistry tools novel biology and...
 
Torch for medicinal chemists
Torch for medicinal chemistsTorch for medicinal chemists
Torch for medicinal chemists
 
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
Discovery and optimization of novel small molecule HIV-1 entry inhibitors usi...
 
Intelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond spIntelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond sp
 
Intelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond spIntelligent library design for protein families and beyond sp
Intelligent library design for protein families and beyond sp
 
Finding and using activity cliffs in 3D: Gaining more SAR information during ...
Finding and using activity cliffs in 3D: Gaining more SAR information during ...Finding and using activity cliffs in 3D: Gaining more SAR information during ...
Finding and using activity cliffs in 3D: Gaining more SAR information during ...
 
Tim Cheeseright, Assessing the Similarities of Compound collections using mol...
Tim Cheeseright, Assessing the Similarities of Compound collections using mol...Tim Cheeseright, Assessing the Similarities of Compound collections using mol...
Tim Cheeseright, Assessing the Similarities of Compound collections using mol...
 
David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'
David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'
David Evans, Eli-Lilly, 'Field-Aligned Matched Pairs'
 
Cresset: 25 year of Fields
Cresset: 25 year of FieldsCresset: 25 year of Fields
Cresset: 25 year of Fields
 
Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'
Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'
Chris Ullman, Isogenica, 'The use of CIS display for drug discovery'
 
Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...
Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...
Simon McIntosh-Smith, University of Bristol, 'Accelerating molecular docking ...
 
Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?
Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?
Raphael Geney, Galapagos, H-bond strength predictions: Could we do better?
 

Recently uploaded

IESVE for Early Stage Design and Planning
IESVE for Early Stage Design and PlanningIESVE for Early Stage Design and Planning
IESVE for Early Stage Design and PlanningIES VE
 
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties ReimaginedEasier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties Reimaginedpanagenda
 
What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024Stephanie Beckett
 
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdfBreaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdfUK Journal
 
Using IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & IrelandUsing IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & IrelandIES VE
 
TopCryptoSupers 12thReport OrionX May2024
TopCryptoSupers 12thReport OrionX May2024TopCryptoSupers 12thReport OrionX May2024
TopCryptoSupers 12thReport OrionX May2024Stephen Perrenod
 
AI mind or machine power point presentation
AI mind or machine power point presentationAI mind or machine power point presentation
AI mind or machine power point presentationyogeshlabana357357
 
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...CzechDreamin
 
WSO2CONMay2024OpenSourceConferenceDebrief.pptx
WSO2CONMay2024OpenSourceConferenceDebrief.pptxWSO2CONMay2024OpenSourceConferenceDebrief.pptx
WSO2CONMay2024OpenSourceConferenceDebrief.pptxJennifer Lim
 
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdfIntroduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdfFIDO Alliance
 
How we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfHow we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfSrushith Repakula
 
ERP Contender Series: Acumatica vs. Sage Intacct
ERP Contender Series: Acumatica vs. Sage IntacctERP Contender Series: Acumatica vs. Sage Intacct
ERP Contender Series: Acumatica vs. Sage IntacctBrainSell Technologies
 
Simplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdf
Simplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdfSimplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdf
Simplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdfFIDO Alliance
 
Working together SRE & Platform Engineering
Working together SRE & Platform EngineeringWorking together SRE & Platform Engineering
Working together SRE & Platform EngineeringMarcus Vechiato
 
Portal Kombat : extension du réseau de propagande russe
Portal Kombat : extension du réseau de propagande russePortal Kombat : extension du réseau de propagande russe
Portal Kombat : extension du réseau de propagande russe中 央社
 
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...FIDO Alliance
 
A Business-Centric Approach to Design System Strategy
A Business-Centric Approach to Design System StrategyA Business-Centric Approach to Design System Strategy
A Business-Centric Approach to Design System StrategyUXDXConf
 
Syngulon - Selection technology May 2024.pdf
Syngulon - Selection technology May 2024.pdfSyngulon - Selection technology May 2024.pdf
Syngulon - Selection technology May 2024.pdfSyngulon
 
Powerful Start- the Key to Project Success, Barbara Laskowska
Powerful Start- the Key to Project Success, Barbara LaskowskaPowerful Start- the Key to Project Success, Barbara Laskowska
Powerful Start- the Key to Project Success, Barbara LaskowskaCzechDreamin
 
Designing for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at ComcastDesigning for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at ComcastUXDXConf
 

Recently uploaded (20)

IESVE for Early Stage Design and Planning
IESVE for Early Stage Design and PlanningIESVE for Early Stage Design and Planning
IESVE for Early Stage Design and Planning
 
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties ReimaginedEasier, Faster, and More Powerful – Notes Document Properties Reimagined
Easier, Faster, and More Powerful – Notes Document Properties Reimagined
 
What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024What's New in Teams Calling, Meetings and Devices April 2024
What's New in Teams Calling, Meetings and Devices April 2024
 
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdfBreaking Down the Flutterwave Scandal What You Need to Know.pdf
Breaking Down the Flutterwave Scandal What You Need to Know.pdf
 
Using IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & IrelandUsing IESVE for Room Loads Analysis - UK & Ireland
Using IESVE for Room Loads Analysis - UK & Ireland
 
TopCryptoSupers 12thReport OrionX May2024
TopCryptoSupers 12thReport OrionX May2024TopCryptoSupers 12thReport OrionX May2024
TopCryptoSupers 12thReport OrionX May2024
 
AI mind or machine power point presentation
AI mind or machine power point presentationAI mind or machine power point presentation
AI mind or machine power point presentation
 
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
Integrating Telephony Systems with Salesforce: Insights and Considerations, B...
 
WSO2CONMay2024OpenSourceConferenceDebrief.pptx
WSO2CONMay2024OpenSourceConferenceDebrief.pptxWSO2CONMay2024OpenSourceConferenceDebrief.pptx
WSO2CONMay2024OpenSourceConferenceDebrief.pptx
 
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdfIntroduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
Introduction to FDO and How It works Applications _ Richard at FIDO Alliance.pdf
 
How we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdfHow we scaled to 80K users by doing nothing!.pdf
How we scaled to 80K users by doing nothing!.pdf
 
ERP Contender Series: Acumatica vs. Sage Intacct
ERP Contender Series: Acumatica vs. Sage IntacctERP Contender Series: Acumatica vs. Sage Intacct
ERP Contender Series: Acumatica vs. Sage Intacct
 
Simplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdf
Simplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdfSimplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdf
Simplified FDO Manufacturing Flow with TPMs _ Liam at Infineon.pdf
 
Working together SRE & Platform Engineering
Working together SRE & Platform EngineeringWorking together SRE & Platform Engineering
Working together SRE & Platform Engineering
 
Portal Kombat : extension du réseau de propagande russe
Portal Kombat : extension du réseau de propagande russePortal Kombat : extension du réseau de propagande russe
Portal Kombat : extension du réseau de propagande russe
 
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
Secure Zero Touch enabled Edge compute with Dell NativeEdge via FDO _ Brad at...
 
A Business-Centric Approach to Design System Strategy
A Business-Centric Approach to Design System StrategyA Business-Centric Approach to Design System Strategy
A Business-Centric Approach to Design System Strategy
 
Syngulon - Selection technology May 2024.pdf
Syngulon - Selection technology May 2024.pdfSyngulon - Selection technology May 2024.pdf
Syngulon - Selection technology May 2024.pdf
 
Powerful Start- the Key to Project Success, Barbara Laskowska
Powerful Start- the Key to Project Success, Barbara LaskowskaPowerful Start- the Key to Project Success, Barbara Laskowska
Powerful Start- the Key to Project Success, Barbara Laskowska
 
Designing for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at ComcastDesigning for Hardware Accessibility at Comcast
Designing for Hardware Accessibility at Comcast
 

Mark Mackey, Cresset, 'Meet Molecular Architect, A new product for understanding SAR and gaining better activity predictions'

  • 1. Meet Molecular Architect Dr Mark Mackey Chief Scientifc Officer
  • 2. Outline Fields, Field points and the good things you can do with them The alignment problem 3D-QSAR using Fields Examples SARS PLpro – small data set, known xtal structure NK3 – large data set, unknown xtal structure
  • 3. Field Points Condensed representation of electrostatic, hydrophobic and shape properties (“protein’s view”) Molecular Field Extrema (“Field Points”) = Positive = Negative = Shape = Hydrophobic 3D Molecular Electrostatic Potential (MEP) Field Points 2D
  • 4. +ve ionic H-bond acceptor Aromatic p cloud ‘H acceptor’ -ve ionic H-bond donor Hydrophobes Aromatic in-plane ‘H donor’ “Stickiest” surfaces (high vdW) Field points give you new insights into your molecule Explanatory Power of Fields = Positive = Negative = Shape = Hydrophobic Field point sizes show importance
  • 5. Field Points have lots of applications Virtual screening Alignment Pharmacophore elucidation Bioisosteres etc
  • 6. Field Points have lots of applications Virtual screening Alignment Pharmacophore elucidation Bioisosteres etc What about 3D QSAR?
  • 7. The Alignment Problem Historically very difficult Early approaches template-based Issues with side chain orientations Some success with docked data sets Easy to fool yourself Correlation/causation
  • 8. Alignment issues Ligand-centric view vs protein-centric Cramer, JCAMD, 2010, DOI 10.1007/s10822-010-9403-z
  • 9. Which is better? “The superior statistical qualities of 3D-QSAR models based on poses that superimpose presumably critical ligand features, rather than docked conformations.” Clark R., JCAMD 2007, p587 Doweyko, J. Comp-Aided Mol. Des., 2004, p 587 Free alignment adds signal, but also noise. Worse statistics, better predictability?
  • 10. N-methyl acetamide Imidazole Field Alignment
  • 11. N-methyl acetamide Imidazole Field Scoring To score a particular alignment, we use the field points of molecule 1 to sample the actual field of molecule 2 Cheeseright et al, J. Chem Inf. Mod., 2006, 665
  • 12. Field Scoring N-methyl acetamide Imidazole To score a particular alignment, we use the field points of molecule 1 to sample the actual field of molecule 2 and vice-versa Cheeseright et al, J. Chem Inf. Mod., 2006, 665
  • 13. Field Sampling Field-point based QSAR descriptors
  • 14. Field Sampling Field-point based QSAR descriptors
  • 15. Advantages Many fewer sample points than grid-based methods E.g. Vegfr2 data set Du et al., J Mol Graph Model. 27 (2009) 642-652
  • 16. Advantages Many fewer sample points than grid-based methods Sample points physically rather than statistically chosen Gauge invariant Consistent framework for alignment and QSAR
  • 17. Initial validation Tested against literature CoMFA datasets 15 datasets with alignments available CoMFA average cross-validated RMSE is 0.72 Field QSAR using CoMFA alignments is 0.74 Simple model (volume indicator variable) is 0.83 Data sets re-aligned using field alignment RMSE 1.00
  • 20. The target PLpro (Papain-like protease) is a DUB target which is critical for the replication of the coronavirus responsible for SARS Crystal structures available with bound ligands from 2 series of compounds: structurally related (PDB entries 3E9S and 3MJ5) Small number of analogues – challenge to see if we can use 3D-QSAR for small data sets
  • 23. Model PLS Components = 5 RMSE = 0.09 RMSEP = 0.38
  • 24. Summary Able to build a predictive 3D-QSAR model based on small number of analogues Guided (by volume of Xtal structure) alignment worked best. Free alignment was OK, but noisier.
  • 26. NK3 example GPCR target (Tachykinin receptor 3) – selectively binds Neurokinin B – target for treatment of neurological disorders such as schizophrenia Three series of inhibitors from Euroscreen Scaffold-1 – 81 compounds with pIC50 (radioligand binding) in range 4.6-8.7 Scaffold-2 – 80 compounds with pIC50 in range 4.8-7.7 Errors in radioligand binding data c. ± 0.4
  • 27. NK3 binding mode For a 3D method you need a 3D alignment FieldAlign can align to a reference FieldTemplater generates the reference FieldTemplater
  • 28. NK3 binding mode prediction FieldTemplater Selection of 3 highly active scaffold-1 compounds plus 2 structurally dissimilar literature NK3 actives (Talnetant and SB-218795). Generated Templates filtered and candidate selected Conformation of most active scaff-1 structure then used as alignment target for other structures
  • 29. 3D-QSAR details Alignment Free alignment to template conformation Field selection Generated Field points for both steric and electrostatic fields, with both sets at independent locations. 80/20 training/test split Most active and least active  training set 2nd most active, 2nd least active  test set Random distribution of remaining compounds
  • 30. Initial models problematic When all else fails, talk to the chemists “Are you using the right tautomer?”
  • 31. NK3 Series 1 RMSE 0.19, RMSEpred 0.64
  • 32. NK3 Series 1 Sterics Electrostatics
  • 33. Extend to scaff-2? Complete lack of predictivity Visual analysis suggests a shift in binding mode for scaff-2 Cross-series QSAR difficult Requires consistent binding modes!
  • 34. NK1 Scaffold 2 RMSEpred 0.60
  • 35. Summary Able to generate models based on alignment to predicted active conformation by templating Independent models within each of two series show reasonable predictivity and can be used to guide further work Cross-series analysis suggests different binding modes for the two series
  • 37. Molecular Architect Initially FieldAlign + QSAR Align your molecules Build models Test models Fit new compounds to models Interactive feedback Add additional alignment options
  • 38. Molecular Architect One tool for molecule designers Align QSAR Pharmacophore elucidation Bioisosteres What do I make next? Beta Q4 2011
  • 39. Acknowledgements Cresset Andy Vinter Tim Cheeseright James Melville Chris Earnshaw Euroscreen Hamid Hoveyda JulienParcq